메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Yutaka Yoneoka (National Cancer Center Hospital Tokyo Japan) Mayumi Kobayashi Kato (National Cancer Center Hospital) Yasuhito Tanase (National Cancer Center Hospital) Masaya Uno (National Cancer Center Hospital) Mitsuya Ishikawa (National Cancer Center Hospital) Takashi Murakami (Shiga University of Medical Science) Tomoyasu Kato (National Cancer Center Hospital)
저널정보
대한산부인과학회 Obstetrics & Gynecology Science Obstetrics & Gynecology Science 제64권 제2호
발행연도
2021.1
수록면
226 - 233 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
ObjectiveThis study aimed to investigate the prognosis of patients with intermediate-risk cervical cancer and to evaluate thenecessity of adjuvant therapy. MethodsWe conducted a retrospective chart review of patients with stage IB?II cervical cancer who underwent type III radicalhysterectomy with pelvic lymphadenectomy between 2008 and 2017. In our institution, radical hysterectomy isperformed as an open surgery and not as a minimally invasive surgery, and adjuvant therapy is not administeredto patients with intermediate-risk cervical cancer. The intermediate-risk group included patients with 2 or more ofthe following factors: tumor size >4 cm, stromal invasion >1/2, and lymphovascular stromal invasion. Intermediateriskpatients with squamous cell carcinoma were included in the I-SCC group, whereas those with endocervicaladenocarcinoma, usual type, or adenosquamous carcinoma were included in the I-Adeno group. ResultsThere were 34 and 18 patients in the I-SCC and I-Adeno groups, respectively. The 5-year recurrence-free survival(RFS) and overall survival rates in the I-SCC group were 90.5% (95% confidence interval [CI], 85.3?95.7%) and 100%(95% CI, 100%), respectively, whereas those in the I-Adeno group were 54.9% (95% CI, 42.0?67.9%) and 76.1%(95% CI, 63.7?88.4%), respectively. Multivariate analysis revealed that endocervical adenocarcinoma, usual type, oradenosquamous carcinoma, and tumor size >4 cm had worse RFS. ConclusionThe I-SCC group had good prognosis without adjuvant therapy; therefore, adjuvant therapy may be omitted in thesepatients. In contrast, the I-Adeno group had poor prognosis without adjuvant therapy; therefore, adjuvant therapyshould be considered in their treatment.

목차

등록된 정보가 없습니다.

참고문헌 (17)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0